HUMA News

Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair

Humacyte To Participate in Upcoming Investor Conferences

Humacyte To Participate in Upcoming Investor Conferences

Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting

Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels

HUMAIN e Infra anuncian Acuerdo Marco de Financiamiento Estratégico para IA e Infraestructura Digital

Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications

Humacyte Announces Planned Marketing Authorization Application for Symvess® in Israel

Humacyte Announces Publication of Long-Term Safety and Efficacy Results of Symvess® in Extremity Trauma Repair

Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital